SUPN - Supernus Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

SUPN is currently covered by 1 analysts with an average price target of $43.63. This is a potential upside of $13.37 (44.18%) from yesterday's end of day stock price of $30.26.

Supernus Pharmaceuticals's activity chart (see below) currently has 59 price targets and 52 ratings on display. The stock rating distribution of SUPN is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 63.62% with an average time for these price targets to be met of 272.8 days.

Highest price target for SUPN is $41, Lowest price target is $41, average price target is $43.63.

Most recent stock forecast was given by DAVID AMSELLEM from PIPER SANDLER on 28-Feb-2024. First documented stock forecast 12-Mar-2015.

Best performing analysts who are covering SUPN - Supernus Pharmaceuticals:

David Buck David Steinberg Annabel Samimy David Amsellem John Boris

Currently out of the existing stock ratings of SUPN, 9 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

41

$11.29 (38.00%)

43

1 months 27 days ago

14/21 (66.67%)

$9.92 (31.92%)

135

Buy

44

$14.29 (48.10%)

40

2 years 4 months 23 days ago

12/15 (80%)

$13.15 (42.63%)

241

Hold

23

4 years 8 days ago

5/7 (71.43%)

$1.85 (8.75%)

100

Buy

65

$35.29 (118.78%)

65

5 years 2 months 27 days ago

2/4 (50%)

$28.85 (79.81%)

234

Buy

57

$32.69 (134.47%)

5 years 5 months 3 days ago

1/2 (50%)

$13.06 (49.50%)

654

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SUPN (Supernus Pharmaceuticals) average time for price targets to be met?

On average it took 272.8 days on average for the stock forecasts to be realized with a an average price target met ratio 63.62

Which analyst has the current highest performing score on SUPN (Supernus Pharmaceuticals) with a proven track record?

DAVID BUCK

Which analyst has the current lower performing score on SUPN (Supernus Pharmaceuticals) with a proven track record?

JOHN BORIS

Which analyst has the most public recommendations on SUPN (Supernus Pharmaceuticals)?

David Buck has 5 price targets and 5 ratings on SUPN

Which analyst is the currently most bullish on SUPN (Supernus Pharmaceuticals)?

David Buck with highest potential upside - $35.29

Which analyst is the currently most reserved on SUPN (Supernus Pharmaceuticals)?

Annabel Samimy with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?